Skip to main content
New and Updated Notices
New Notices
- New Notice of Intent to Revise: Norflurane (posted 10-May-2024)
- New Pending Revision Notice: Doxycycline Capsules (posted 26-Apr-2024)
- New Pending Revision Notice: Doxycycline Capsules (posted 26-Apr-2024)
- New Pending Revision Notice: Oxcarbazepine Oral Suspension (posted 26-Apr-2024)
- New Notice of Intent to Revise: <383> Cured Silicone Elastomers for Pharmaceutical Packaging and Manufacturing Components (posted 26-Apr-2024)
- New Notice of Intent to Revise: Dimethyl Fumarate Delayed-Release Capsules (posted 26-Apr-2024)
- New Notice of Intent to Revise: Protriptyline Hydrochloride (posted 26-Apr-2024)
- New Notice of Intent to Revise: Rifampin, Rifampin Capsules, Rifampin for Injection, Rifampin and Isoniazid Capsules, and Rifampin, Isoniazid, and Pyrazinamide Tablets (posted 26-Apr-2024)
- New General Chapter Prospectus: <1155> Iron Colloidal Formulations- Characterization Methods (posted 26-Apr-2024, input deadline 26-May-2024)
- New General Chapter Prospectus: <1156> Product Quality and Performance Tests for the Microsphere Drug Products (posted 26-Apr-2024, input deadline 26-May-2024)
- New Publication Announcement: Chemical Information Updates (posted 26-Apr-2024)
- New Publication Announcement: Monographs Affected by Revisions to <1031> The Biocompatibility of Materials Used in Drug Containers, Medical Devices, and Implants (posted 26-Apr-2024)
- New Publication Announcement: Monographs Affected by Revisions to <88> Biological Reactivity Tests, In Vivo (posted 26-Apr-2024)
- New Publication Announcement: USP-NF Online: Official Dates for Monographs in Redesigned Format (posted 26-Apr-2024)
- New General Announcement: <1245> Compaction Simulation Preview (posted 26-Apr-2024)
- New Publication Announcement: USP-NF 2023, Issue 2: Metoprolol Succinate Extended-Release Tablets (posted 12-Apr-2024)
- New Notice of Intent to Revise: Succinic Acid (posted 12-Apr-2024)
- New Pending Monograph Notice: Carbamazepine Extended-Release Tablets (posted 29-Mar-2024)
- New Pending Monograph Notice: Doxycycline Capsules (posted 29-Mar-2024)
- New General Chapter Prospectus: Process Analytical Technology- Definition, Attributes, Enablers, and Use Cases (posted 29-Mar-2024, input deadline 28-Apr-2024)
- New General Announcement: Proposed Compendial Approach for the Implementation of <60> MIcrobiological Examination of Nonsterile Products ̶ Tests for Burkholderia Cepacia Complex (BCC) (posted 29-Mar-2024, input deadline 27-Jun-2024)
- New Notice of Intent to Revise: Changes to General Notices, Section 1 (posted 28-Feb-2024)
- New Notice of Intent to Revise: Cetyl Palmitate (posted 23-Feb-2024)
- New Notice of Intent to Revise: Dapsone Tablets (posted 23-Feb-2024)
- New Notice of Intent to Revise: Methylprednisolone Injectable Suspension (posted 23-Feb-2024)
- New Notice of Intent to Revise: Polyethylene Glycol (posted 23-Feb-2024)
- New Notice of Intent to Revise: Roflumilast (posted 23-Feb-2024)
- New Notice of Intent to Revise: Sucrose (posted 23-Feb-2024)
- New General Chapter Prospectus: <1785> Osmolality/Osmolarity- Practical Considerations (posted 23-Feb-2024; input deadline 24-Mar-2024)
- New Publication Announcement: Chemical Information Updates (posted 12-Feb-2024)
- New Publication Announcement: Monographs Affected by Revision to <541> Titrimetry (posted 12-Feb-2024)
- New Publication Announcement: Update on the Extended Implementation Date for the Omission of Monographs for Carbomer 934, Carbomer 934P, Carbomer 940, Carbomer 941, and Carbomer 1342 (posted 01-Feb-2024)